Search hospitals > California > San Francisco
California Pacific Medical Center
Claim this profileSan Francisco, California 94115
Global Leader in HIV Infection
Global Leader in Human Immunodeficiency Virus Infection
Conducts research for Amyotrophic Lateral Sclerosis
Conducts research for AIDS
Conducts research for Pancreatic Cancer
228 reported clinical trials
9 medical researchers
Summary
California Pacific Medical Center is a medical facility located in San Francisco, California. This center is recognized for care of HIV Infection, Human Immunodeficiency Virus Infection, Amyotrophic Lateral Sclerosis, AIDS, Pancreatic Cancer and other specialties. California Pacific Medical Center is involved with conducting 228 clinical trials across 261 conditions. There are 9 research doctors associated with this hospital, such as Ari Baron, MD, Christian Spies, MD, Jonathan Katz, MD, and Stewart Cooper, Dr..Top PIs
Ari Baron, MDAlta Bates Summit Medical Center-Herrick Campus8 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
30 reported clinical trials
68 drugs studied
Christian Spies, MDCalifornia Pacific Medical Center7 years of reported clinical research
Studies Tricuspid Valve Regurgitation
Studies Tricuspid Regurgitation
4 reported clinical trials
7 drugs studied
Jonathan Katz, MDCalifornia Pacific Medical Center Research Institute4 years of reported clinical research
Studies Amyotrophic Lateral Sclerosis
Studies Prostate Cancer
4 reported clinical trials
7 drugs studied
Stewart Cooper, Dr.California Pacific Medical Center3 years of reported clinical research
Studies Chronic Hepatitis B
Studies Hepatitis
2 reported clinical trials
2 drugs studied
Clinical Trials running at California Pacific Medical Center
Ovarian Cancer
Endometrial Cancer
Stroke
Amyotrophic Lateral Sclerosis
Non-Small Cell Lung Cancer
Breast Cancer
Prostate Cancer
Colorectal Cancer
Head and Neck Cancers
Spinal Muscular Atrophy
PARG Inhibitor
for Advanced Cancers
This trial is testing a new drug called IDE161 to see if it is safe and effective for patients with advanced cancers that have specific genetic changes. The drug works by preventing cancer cells from repairing their DNA, which can lead to their death.
Recruiting1 award Phase 14 criteria
Carboplatin + Mirvetuximab Soravtansine
for Ovarian Cancer
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess the safety and efficacy of neoadjuvant carboplatin and mirvetuximab soravtansine in participants with folate receptor alpha (FRα) -expressing advanced-stage serous epithelial ovarian, fallopian tube or primary peritoneal cancer (EOC). Mirvetuximab Soravtansine (MIRV) is an investigational antibody drug conjugate designed to selectively kill cancer cells. The antibody (protein) part of MIRV targets tumors by delivering a cell-killing drug to cancer cells carrying a protein called folate receptor alpha (FRα). This is a single arm study in adult participants with advanced-stage Fédération Internationale de Gynécologie et d'Obstétrique (FIGO) III-IV FRα-expressing serous EOC. Around 140 participants will be enrolled in the study at approximately 80 sites in the United States. Participants will receive intravenous infusion of MIRV in combination with carboplatin on day 1 of each cycle, every 21 days for up to 6 - 9 Cycles. The total study duration will be approximately 3 years . There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic and may require frequent medical assessments, blood tests, and scans.
Recruiting1 award Phase 24 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at California Pacific Medical Center?
California Pacific Medical Center is a medical facility located in San Francisco, California. This center is recognized for care of HIV Infection, Human Immunodeficiency Virus Infection, Amyotrophic Lateral Sclerosis, AIDS, Pancreatic Cancer and other specialties. California Pacific Medical Center is involved with conducting 228 clinical trials across 261 conditions. There are 9 research doctors associated with this hospital, such as Ari Baron, MD, Christian Spies, MD, Jonathan Katz, MD, and Stewart Cooper, Dr..
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.